FDA Partner Gary Yingling to present on Identification and Ethical Reporting of Suspected Fraud or Misconduct at the ACRP 2014 Global Conference & Exhibition in San Antonio.
Gary’s session will focus on what a CRA, CRC or other member of a clinical trial team should do when they have uncovered fraudulent data or unsafe clinical practices in a clinical trial. The session will also discuss why clinical research professionals should develop skills in detecting and preventing fraud or errors as well as share the regulatory background of fraud and the criteria for characterizing misconduct as fraud.
Sunday, April 27, 2014
Henry B. Gonzalez Convention Center
Mission Room 103A, Street Level
San Antonio, TX